TLR4 is an LPS receptor and elevation of LPS in most animal models of NAFLD causes hepatic steatosis, hepatic insulin resistance, and increased liver weight, making TLR4-LPS the key pathway promoting the development of NAFLD [176]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.